You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 2, 2024

ISOSORBIDE MONONITRATE Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


When do Isosorbide Mononitrate patents expire, and when can generic versions of Isosorbide Mononitrate launch?

Isosorbide Mononitrate is a drug marketed by Accord Hlthcare, Actavis Elizabeth, Alkermes Gainesville, Aurobindo Pharma, Chartwell Molecular, Dexcel Ltd, Hikma Intl Pharms, Ivax Sub Teva Pharms, Riconpharma Llc, Shandong, Skyepharma Ag, Strides Pharma, Torrent Pharms, Zydus Hlthcare, Zydus Pharms, Ani Pharms, and Hikma Pharms. and is included in twenty NDAs.

The generic ingredient in ISOSORBIDE MONONITRATE is isosorbide mononitrate. There are thirty-seven drug master file entries for this compound. Twenty-four suppliers are listed for this compound. Additional details are available on the isosorbide mononitrate profile page.

DrugPatentWatch® Litigation and Generic Entry Outlook for Isosorbide Mononitrate

A generic version of ISOSORBIDE MONONITRATE was approved as isosorbide mononitrate by CHARTWELL MOLECULAR on October 30th, 1998.

  Sign Up

AI Research Assistant
Questions you can ask:
  • What is the 5 year forecast for ISOSORBIDE MONONITRATE?
  • What are the global sales for ISOSORBIDE MONONITRATE?
  • What is Average Wholesale Price for ISOSORBIDE MONONITRATE?
Summary for ISOSORBIDE MONONITRATE
Drug patent expirations by year for ISOSORBIDE MONONITRATE
Drug Prices for ISOSORBIDE MONONITRATE

See drug prices for ISOSORBIDE MONONITRATE

Drug Sales Revenue Trends for ISOSORBIDE MONONITRATE

See drug sales revenues for ISOSORBIDE MONONITRATE

Recent Clinical Trials for ISOSORBIDE MONONITRATE

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Al-Azhar UniversityEarly Phase 1
Cairo UniversityPhase 1
Suez Canal UniversityEarly Phase 1

See all ISOSORBIDE MONONITRATE clinical trials

Pharmacology for ISOSORBIDE MONONITRATE
Drug ClassNitrate Vasodilator
Physiological EffectVasodilation
Anatomical Therapeutic Chemical (ATC) Classes for ISOSORBIDE MONONITRATE

US Patents and Regulatory Information for ISOSORBIDE MONONITRATE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Actavis Elizabeth ISOSORBIDE MONONITRATE isosorbide mononitrate TABLET;ORAL 075037-001 Oct 30, 1998 AB RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Torrent Pharms ISOSORBIDE MONONITRATE isosorbide mononitrate TABLET, EXTENDED RELEASE;ORAL 200495-001 Jun 3, 2011 AB RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Strides Pharma ISOSORBIDE MONONITRATE isosorbide mononitrate TABLET, EXTENDED RELEASE;ORAL 090598-001 Aug 11, 2010 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Torrent Pharms ISOSORBIDE MONONITRATE isosorbide mononitrate TABLET, EXTENDED RELEASE;ORAL 200495-002 Jun 3, 2011 AB RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Strides Pharma ISOSORBIDE MONONITRATE isosorbide mononitrate TABLET, EXTENDED RELEASE;ORAL 090598-002 Aug 11, 2010 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Accord Hlthcare ISOSORBIDE MONONITRATE isosorbide mononitrate TABLET, EXTENDED RELEASE;ORAL 209684-001 Oct 24, 2017 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Ivax Sub Teva Pharms ISOSORBIDE MONONITRATE isosorbide mononitrate TABLET, EXTENDED RELEASE;ORAL 075448-002 Aug 7, 2001 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.